Bipolar Disorder

Why the field lacks behind in effective diagnostic tools, which could better inform tailored therapy.

How have natural-cause mortality rates changed over time in an international population?

How psychiatry can catch up to other specialties in accurate, timely diagnostics based on molecular breakthrough.

A public health expert shares insight on the positives and pitfalls learned from stigma-reduction campaigns.

Investigators find link between childhood psychopathology and polygenetic scores in a number of disorders, but not bipolar disorder.

PDUFA target action date set for November 15, 2020 for the new combination olanzapine/samidorphan treatment.

Investigators found that family involvement in treatment can prolong the time between recovery and the next mood episode.

Medical students felt better about seeking mental health help after they learned of senior physicians who sought treatment for their own mental illnesses.

Patients who presented at the emergency department with deliberate self-harm were more likely to have suicide mortality than those with suicidal ideation or other concerns.

In a new study, investigators link sleep duration for adolescents between 6-12 with developing psychiatric disorders 2 years later.

By screening during primary care visits, patients are now more aware than ever about their possibility of depression and other mental health disorders.

Having a dog or cat in the first 12 years of a child's life could reduce the risk of serious psychiatric disorders later on.

New data suggests that bipolar disorder 1 is linked with longer sleep durations, while bipolar disorder II is tied to insomnia.

How can clinicians and policy makers collaborate to improve the standing of mental health in the US?

A discussion with a director from the American Public Health Association on what drives the increasing burden of mental illness in the US.

How physicians in a shrinking field have taken on a greater burden of leadership roles in patient care.

How does psychiatry access differ among patients, and how should it become individualized?

Bipolar depression can be difficult to treat and is often misdiagnosed.

A new set of 22 recommendations include a combination of universal screenings, medication, and other preventative initiatives in an effort to drive down veteran suicide rates.

In a comprehensive new study, investigators discover unique patterns in the brains of both family members and patients with psychotic disorders, including bipolar disorder and schizophrenia.

In an extensive population-based study, investigators link children with IBD with an increased risk of any psychiatric disorder.

A new study looks at the links between ADHD and bipolar disorder in children and adolescents.

This week's #DocTalk tweet chat generated discussion on the means by which healthcare professionals can influence mental health policies and understanding.

Allergan announced the FDA approved a New Drug Application for Vraylar for the treatment of depressive episodes associated with bipolar depression.

Investigators presented data from a 2-year, open-label study into the efficacy and safety of lurasidone in children 10 to 17 years old at APA 2019.

The antipsyhoctic could receive a new indication in 2019, and though the field of bipolar disorder care is far from perfect, it should improve with this addition.

The study focused on patients with bipolar or depressive disorder.

A retrospective study showed which patients with substance use disorder may have less successful antiepileptic drug treatment.

Most of the patients in the study were taking concomitant antidepressants and/or antipsychotics, and mood disorders remained stable during treatment with valbenazine.

Tardive dyskinesia due to lithium treatment is still rare, but the antipsyhotic therapy substitute was linked to at least 1 particular patient case.